en
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Open in Telegram

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Show more

๐Ÿ“ˆ Analytical overview of Telegram channel ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Channel ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) in the Arabic language segment is an active participant. Currently, the community unites 13 237 subscribers, ranking 1 944 in the Medicine category and 5 753 in the Saudi Arabia region.

๐Ÿ“Š Audience metrics and dynamics

Since its creation on ะฝะตะฒั–ะดะพะผะพ, the project has demonstrated rapid growth, gathering an audience of 13 237 subscribers.

According to the latest data from 03 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 94 over the last 30 days and by -20 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 28.53%. Within the first 24 hours after publication, content typically collects 7.27% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 3 779 views. Within the first day, a publication typically gains 963 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 37.
  • Thematic interests: Content is focused on key topics such as ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ.

๐Ÿ“ Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Thanks to the high frequency of updates (latest data received on 04 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

13 237
Subscribers
-2024 hours
-1437 days
+9430 days
Posts Archive
ู…ู…ูƒู† ุชููŠุฏูƒู… ุงุฎุฑ ู…ุญุงุถุฑุฉ ุจุงู„ูƒุงู†ุณุฑ ุงู„ูŠูˆู… ุชู†ุฒู„ ุงู† ุดุงุก ุงู„ู„ู‡

- ุงู„ุฑุณุงู„ู‡ ุ› https://t.me/pharam2025

ู…ู† ุงู„ูƒูŠุณุงุช ุงู„ู…ู‡ู…ุฉ ุฌุฏุง ูˆุงู„ูŠ ู…ู…ูƒู† ุชุฌูŠูƒู… ุจุงู„ูˆุฒุงุฑูŠโœ๏ธ ุงุฐุง patient ุชุนุงู†ูŠ ู…ู† ุงู„ breast cancer ูˆู‡ุงูŠ ุงู„ู…ุฑุฃุฉ ู‡ูŠ premenopausal ูŠุนู†ูŠ ู‡ู†ุง
ู…ู† ุงู„ูƒูŠุณุงุช ุงู„ู…ู‡ู…ุฉ ุฌุฏุง ูˆุงู„ูŠ ู…ู…ูƒู† ุชุฌูŠูƒู… ุจุงู„ูˆุฒุงุฑูŠโœ๏ธ ุงุฐุง patient ุชุนุงู†ูŠ ู…ู† ุงู„ breast cancer ูˆู‡ุงูŠ ุงู„ู…ุฑุฃุฉ ู‡ูŠ premenopausal ูŠุนู†ูŠ ู‡ู†ุง ุงู„ู…ุฑุงุฉ ุจุนุฏู‡ุง ุดุงุจุฉ ูˆุนุฏู‡ุง ู‚ุฏุฑุฉ ุนุงู„ุงู†ุฌุงุจ๐Ÿ‘ฉโ€๐Ÿฆฐ ุงู„ุงูุถู„ ู†ุณุชุฎุฏู… ุงู„ tamoxifen ู„ุงู† ู…ุง ุงูƒุฏุฑ ุงู†ุทูŠู‡ุง ุนู„ุงุฌ ูŠูƒูˆู† antagonist ุนู„ู‰ ุงู„ uterus ู…ุซู„ ุงู„ Raloxifen ุจูŠู†ู…ุง ุจ ุงู„ postmenopausal ู‡ู†ุง ุงู„ู…ุฑุฃุฉ ูˆุงุตู„ุฉ ุฅู„ู‰ ุณู† ุงู„ูŠุฃุณ ูŠุนู†ูŠ ู…ุงูƒูˆ ุญุงุฌุฉ ู„ู„ endometrium ๐Ÿ‘ต๐Ÿป ูˆุชุนุงู†ูŠ ู…ู† ุงู„ breast cancer ู‡ู†ุง ุงู„ุงุฎุชูŠุงุฑ ุงูƒูŠุฏ ุงู„ raloxifen ุญุชู‰ ู†ู‚ู„ู„ ู…ู† ู…ุฎุงุทุฑ ุงู„ endometrium cancer ุงู„ูŠ ูŠุณุจุจู‡ุง ุงู„ Tamoxifen
ู…ู„ุฎุต ุงู„ูƒู„ุงู… Premenopausal women ุชุนุงู†ูŠ ู…ู† breast cancer ู ุงู„ุนู„ุงุฌุงุช ู‡ูŠ Tamoxifen ุงูˆ GnRH analog ex: leuprolide ูˆุงุฐุง postmenopausal women ุชุนุงู†ูŠ ู…ู† breast cancer ู ุงู„ุฎุท ุงู„ุนู„ุงุฌูŠ ุงู„ุงูˆู„ Aromatase inhibitors ex: letrozole ุงูˆ ู†ู†ุทูŠ Raloxifen
ูˆุฑูƒุฒูˆุง ู‡ู… ุฎุงู ูŠุฑุจุทูˆู† ุงู„ูƒูŠุณ ุงู†ู‡ ุงู„ุจูŠุดู†ุช ุชุนุงู†ูŠ ู…ู† ุณุฑุทุงู† ุงู„ุซุฏูŠ ูˆ ุนุฏู‡ุง osteoporosis ู‡ุดุงุดุฉ ุนุธุงู… ู ู‡ู†ุง ุงู„ุงูุถู„ ู†ุฎุชุงุฑ Selective estrogen receptor modulator (Raloxifen or Tamoxifen) ูˆุงู„ุงุฎุชูŠุงุฑ ุจูŠู†ู‡ู… ูŠูƒูˆู† ุญุณุจ ุงู„ุนู…ุฑ
ุงู„ุตูˆุฑุฉ ุชูˆุถุญ ูˆุดุฑุญุชู‡ุง ุจุงู„ุชูุตูŠู„ ุจ ุงู„ู…ุญุงุถุฑุฉ ุฑู‚ู… 7 ู…ู† anti cancer #cancer ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

ุงุณุฆู„ุฉ ุงู„ DMARD AND GOUT ุฌุงู‡ุฒุฉ ุงุฐุง ูˆุงุญุฏ ูŠุฑูŠุฏ ูŠุฎุชุจุฑ ู†ูุณู‡ ูˆูŠุฑุงุฌุน ู…ุนู„ูˆู…ุงุชู‡

ุงู„ุณู„ุงู… ุนู„ู‰ ุณุงุจุนโ€Œ ุงู„ุญุฌุฌ ุงู„ุฃุทู‡ุงุฑ ุงู„ู…ุนุฐุจ ู…ู† ู‚ูุจูŽู„ู ุทูˆุงุบูŠุช ุนุตุฑู‡ ููŠ ุทูˆุงู…ูŠุฑ ุงู„ุณุฌูˆู† ูŠุงู…ูˆุณู‰ ุจู† ุฌุนูุฑ ุงูŠู‡ุง ุงู„ูƒุงุธู… ูŠุงุณูŠุฏู†ุง ูˆู…ูˆู„ุงู†ุง ุงู† ุชูˆ
ุงู„ุณู„ุงู… ุนู„ู‰ ุณุงุจุนโ€Œ ุงู„ุญุฌุฌ ุงู„ุฃุทู‡ุงุฑ ุงู„ู…ุนุฐุจ ู…ู† ู‚ูุจูŽู„ู ุทูˆุงุบูŠุช ุนุตุฑู‡ ููŠ ุทูˆุงู…ูŠุฑ ุงู„ุณุฌูˆู† ูŠุงู…ูˆุณู‰ ุจู† ุฌุนูุฑ ุงูŠู‡ุง ุงู„ูƒุงุธู… ูŠุงุณูŠุฏู†ุง ูˆู…ูˆู„ุงู†ุง ุงู† ุชูˆุฌู‡ู†ุง ูˆุงุณุชุดูุนู†ุง ูˆุชูˆุณู„ู†ุง ุจูƒ ุงู„ู‰ ุงู„ู„ู‡ ูˆู‚ุฏู…ู†ุงูƒ ุจูŠู† ูŠุฏูŠ ุญุงุฌุงุชู†ุง .. ูŠุงูˆุฌูŠู‡ุง ุนู†ุฏ ุงู„ู„ู‡ ุงุดูุน ู„ู†ุง ุนู†ุฏ ุงู„ู„ู‡ ุนุธู… ุงู„ู„ู‡ ุงุฌูˆุฑู†ุง ูˆุงุฌูˆุฑูƒู… ุจุฐูƒุฑู‰ ุงุณุชุดู‡ุงุฏ ุงู„ุฅู…ุงู… ุงู„ู…ุธู„ูˆู… ุงู„ู…ุณู…ูˆู… ุณูŠุฏูŠ ูˆู…ูˆู„ุงูŠ ู…ูˆุณู‰ ุจู† ุฌุนูุฑ ุงู„ูƒุงุธู… ุนู„ูŠู‡ู… ุงู„ุณู„ุงู…

ูˆุฏุงุนุชูƒู… ุดุงุฑุญู‡ู† ๐Ÿ˜‚ ู‡ูˆุงูŠ ูŠุณุฃู„ูˆู†ูŠ ุนู„ูŠู‡ู† ู„ูŠุด ู…ุง ุดุงุฑุญู‡ู†ุŒ ู…ูˆ ู…ู‡ู…ุงุชุŸ ุงุฎุฑ ูฃ ุณู„ุงูŠุฏุงุช ู…ู† ุงู„ู…ู„ุฒู…ุฉ ุงู„ุซุงู†ูŠุฉ ู…ูˆุฌูˆุฏุฉ ุถู…ู† ู‚ุงุฆู…ุฉ ุดุฑุญ ุงู„ DMARD ู„ุงู† ู‡ูŠ ุชุงุจุนุฉ ุงู„ู‡ุง ู ุฎู„ูŠุชู‡ ูˆูŠุงู‡ู† ุงุณู… ุงู„ู…ุญุงุถุฑุฉ Traditional DMARD

ู…ุฑุญุจุง ุดุจุงุจ ุงู† ุดุงุก ุงู„ู„ู‡ ุชูƒูˆู†ูˆู† ุจุฎูŠุฑ ุจุงู„ู†ุณุจุฉ ู„ุฑุงุจุท ุงุณุฆู„ุฉ ู…ุญุงุถุฑุฉ ุงู„ Anti inflammatory ุถูุชู‡ุง ุจุงู„ุฑุณุงู„ุฉ ุงู„ู…ุซุจุชุฉ ููŠ Exam

https://youtu.be/E56leRN5w8c ูกูขูฃ ุงู„ู‰ ูกูขูจ

1. https://youtu.be/TNKWgcFPHqw?si=oWpbTIs3Ph-sNrOO 2. https://youtu.be/O63nZ-5uvzg?si=Hte25V2fc3uFETTd ุงุฑูŠุฏ ุชุดูˆููˆู† ู‡ุงูŠ ุงู„ู…ู‚ุทุนูŠู† ุนู† ุนู…ู„ูŠุฉ ุงุณุชู†ุณุงุฎ ุงู„ DNA ู„ุงู† ุงู„ุงู†ุฒูŠู…ุงุช ูƒู„ุด ู…ู‡ู…ุฉ ุจ ุงุฏูˆูŠุฉ ุงู„ูƒุงู†ุณุฑ ู…ู‚ุงุทุน ู‚ุตูŠุฑุฉ ูˆู…ุง ุชุงุฎุฐ ูˆู‚ุช ุจุณ ุชููŠุฏูƒู… ุงู„ู…ู‡ู… ุดูˆููˆู‡ู† ุญุชู‰ ุชุณุชูุงุฏูˆู† ูˆุชุณู‡ู„ ุนู„ูŠูƒู… ุงู„ู…ุญุงุถุฑุงุช #cancer

ู…ุฌู…ูˆุนุฉ Antimetabolite ู…ุซู„ ู…ุง ุงุชูู‚ู†ุง ุชูƒูˆู† cell cycle specific drug ุขู„ูŠุฉ ุนู…ู„ู‡ุง ุนู„ู‰ ู…ุฑุญู„ุฉ ู…ุญุฏุฏุฉ ู…ู† ู…ุฑุงุญู„ cell cycle ุงู„ูŠ ู‡ูŠ S Pha
ู…ุฌู…ูˆุนุฉ Antimetabolite ู…ุซู„ ู…ุง ุงุชูู‚ู†ุง ุชูƒูˆู† cell cycle specific drug ุขู„ูŠุฉ ุนู…ู„ู‡ุง ุนู„ู‰ ู…ุฑุญู„ุฉ ู…ุญุฏุฏุฉ ู…ู† ู…ุฑุงุญู„ cell cycle ุงู„ูŠ ู‡ูŠ S Phase ูˆู‚ุณู…ู†ุงู‡ุง ุงู„ู‰ 3 ู…ุฌุงู…ูŠุน ูˆู‡ูŠ:
๐Ÿ”ดAnti folate [PPM] Pemetrexed Pralatrexate Methotrexate
๐Ÿ”ดPurine analog Guanine analog: 6 mercaptopurine 6 thioguanine Adenosine analog: Fludarabine Cladribine
๐Ÿ”ดPyrimidine analog Thymidine inhibitors: 5 fluorouracil Capecitabine Cytidine inhibitors: Cytarabine Azacitidine Gemcitabine
#cancer ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

ุจุฎุตูˆุต ุงู„ุฎุทุฃ ุงู„ูŠ ุฐูƒุฑุชู‡ ุจู†ู‡ุงูŠุฉ ุงู„ู…ุญุงุถุฑุฉ ุชูƒุฏุฑูˆู† ุชุฑุฌุนูˆู† ู„ู„ side effect ู…ุงู„ุช MTX ุจู…ุญุงุถุฑุฉ Traditional disease Modifying Antirheumatic ุงูˆ ุชุนุชู…ุฏูˆู† ุนู„ู‰ ุงู„ุตูˆุฑุฉ ุงู„ูŠ ุถูุชู‡ุง ุจุงู„ุดุฑุญ ู…ู† ู…ุตุฏุฑ lippincott ุงู„ู…ู‡ู… ู„ุง ุชุนุชู…ุฏูˆู† ุนู„ู‰ ุงู„ุฎุทุฃ ุงู„ู…ูˆุฌูˆุฏ ู„ุงู† ุงู„ุงุซุงุฑ ุงู„ู…ุฐูƒูˆุฑุฉ ุชุฎุต hydroxychloroquine ู…ุง ุชุฎุต MTX

ุชูˆุถูŠุญ ุจุณูŠุท ุดุจุงุจ ุจู†ู‡ุงูŠุฉ ู‡ุฐู‡ ุงู„ู…ู„ุฒู…ุฉ ู…ูˆุถูˆุน ุงุณู…ู‡ Traditional disease Modifying Antirheumatic Drugs ู‡ุฐุง ุงู„ู…ูุฑูˆุถ ูŠู†ุถุงู ูˆูŠ ุงู„ู…ู„ุฒู…ุฉ ุฑู‚ู… 3 ุงู„ู…ู‡ู… ู…ุทู„ูˆุจ ูˆ ู…ุดุฑูˆุญ ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ู…ุง ุชุฑูƒุชู‡ ุงู†ุง ุชู„ูƒูˆู†ู‡ ุจู‚ุงุฆู…ุฉ ุดุฑุญ ุงู„ DMARD

โญ• ุงูˆู„ ู…ุฌู…ูˆุนุฉ ุงุณุงุณูŠุฉ ู…ู† ุงุฏูˆูŠุฉ ุงู„ูƒุงู†ุณุฑ ู‡ูŠ Antimetabolites โญ• ู‡ุฐู‡ ุงู„ู…ุฌู…ูˆุนุฉ ุนู…ู„ู‡ุง ุงู†ู‡ ุชูˆู‚ู ู…ุณุงุฑุงุช ุงูŠุถูŠุฉ ู…ู‡ู…ุฉ ูˆุถุฑูˆุฑูŠุฉ ููŠ ุงู†ู‚ุณุงู… ูˆู†ู…ูˆ ุงู„ุฎู„ุงูŠุง ุงู„ุณุฑุทุงู†ูŠุฉ ูˆู‡ุฐู‡ ุงู„ู…ุฌูˆุนุฉ ุชุฃุซูŠุฑู‡ุง ูŠูƒูˆู† ุนู„ู‰ S phase of cell cycle ูุชูƒูˆู† cell cycle specific drug ู‡ุฐู‡ ุงู„ู…ุฌู…ูˆุนุฉ ุงู„ุงุณุงุณูŠุฉ ุฑุญ ุชู†ู‚ุณู… ุฅู„ู‰ ุนุฏุฉ ู…ุฌุงู…ูŠุน ูุฑุนูŠุฉ ุงู„ู…ุฌู…ูˆุนุฉ ุงู„ุฃูˆู„ู‰ ู‡ูŠ antifolate ุงูˆ folic acid antagonist
ุจูŠู‡ุง 3 ุนู„ุงุฌุงุช ู†ุฌู…ุนู‡ู† ุจู…ุฎุชุตุฑ PPM Pemetrexed Pralatrexate Methotrexate MTX
โญ• ุขู„ูŠุฉ ุงู„ุนู…ู„ ุฑุญ ุชู…ู†ุน ุชุญูˆูŠู„ ุงู„ folic acid ุงู„ู‰ ุงู„ active form ุงู„ูŠ ู‡ูˆ Tetrahydrofolic acid FH4 ู…ู† ุฎู„ุงู„ ุชุซุจูŠุท ุงู†ุฒูŠู… ุงุณู…ู‡ Dihydrofolate reductase DHFR ูˆุจุงู„ุชุงู„ูŠ ุฑุญ ู†ูˆู‚ู ู‡ุฐุง ุงู„ู…ุณุงุฑ ูˆู†ู…ู†ุน ุชุตู†ูŠุน ุงู„ purine ุงู„ูŠ ุชุนุชุจุฑ ุถุฑูˆุฑูŠุฉ ููŠ ุชุตู†ูŠุน ุงู„ DNA ุงู„ Pemetrexed ุขู„ูŠุฉ ุนู…ู„ู‡ ู…ุดุงุจู‡ุฉ ูˆุงู„ูุฑู‚ ุงู†ู‡ ูŠุซุจุท ุงู†ุฒูŠู…ุงุช ุซุงู†ูŠุฉ ุงูƒุซุฑ ู…ู† ุถู…ู† ู‡ุฐุง ุงู„ู…ุณุงุฑ ู…ุซู„ุง thymidylate synthase ู…ูˆุถุญุฉ ุจุงู„ูƒุงู…ู„ ููŠ ุงู„ููŠุฏูŠูˆ
ุญุชู‰ ุงุชุฎู„ุต ู…ู† ุฏูˆุงุก ุงู„ MTX ุงูƒูˆ ุทุฑูŠู‚ุชูŠู† : 1. ู†ุฒูŠุฏ Dihydrofolate ุจู…ู‚ุฏุงุฑ 1000 ู…ุฑุฉ ู…ู† ุฎู„ุงู„ ุงุนุทุงุก DHF 2. ู†ู†ุทูŠ folinic acid ุงู„ูŠ ู‡ูˆ leucovorin
โญ•ุงุฏูˆูŠุฉ ู‡ุฐู‡ ุงู„ู…ุฌู…ูˆุนุฉ ู…ู…ูƒู† ุชุณุจุจ ู†ู‚ุต ุจ Folic acid and Vit B12 ูˆุจุงู„ุชุงู„ูŠ ู…ู…ูƒู† ุชุณุจุจ anemia ูˆ git toxicity ู ุงู„ุงูุถู„ ุงู†ู‡ ู†ู†ุทูŠ ูˆูŠุงู‡ุง supplement ู…ู† ุงู„ FA ูˆุงู„ B12 ุญุชู‰ ู†ู‚ู„ู„ ู…ู† ู‡ุฐู‡ ุงู„ุชุฃุซูŠุฑุงุช โญ•ูˆุงุฎูŠุฑุง ุงู„ Pemetrexed ูŠุณุจุจ cutaneous reactions ุงุญู…ุฑุงุฑ ูˆุชู‚ุฑุญุงุช ุจุงู„ุฌู„ุฏ ู ุงู„ุงูุถู„ ู‚ุจู„ ุงุณุชุฎุฏุงู…ู‡ Pretreatment ู†ู†ุทูŠ Corticosteroids ุญุชู‰ ู†ู‚ู„ู„ ู…ู† ู‡ุฐุง ุงู„ุชุฃุซูŠุฑ
#cancer ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

https://youtu.be/dkOeW7Kirus ุตูุญุฉ ูกู ูฉ ุงู„ู‰ ูกูกูฅ